Series B startup

Who invested in Trioar

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$16Mraised across 1 round since 2025, from 1 source

Latest round
Series B, $16MJul 2025
Investors
3
See who backed them

The rounds

  1. Jul 2025

Everyone who backed them

KB InvestmentVC firm1round
IMM InvestmentVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Trioar as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Kiwoom InvestmentVC firmPer its own site

Quick answers about Trioar

Who invested in Trioar?

Trioar's investors include KB Investment, IMM Investment and Shinhan Venture Investment.

How much has Trioar raised?

Trioar has raised $16M across 1 round since 2025.

When did Trioar last raise?

Trioar's most recent round was a Series B of $16M in Jul 2025.

What was Trioar's biggest round?

Its most recent round, $16M in Jul 2025, is also its largest on record.

Who backed Trioar first?

Trioar's first round on record, in Jul 2025, was backed by KB Investment, IMM Investment and Shinhan Venture Investment.

What stage is Trioar at?

Trioar's latest named round is a Series B, in Jul 2025.

Companies like Trioar

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.